Moderna tops public biopharma raises with $1.34B to help fund its COVID-19 vaccine May 19, 2020 By Karen Carey No Comments Representing the highest amount ever raised by a public biopharma company on a U.S. exchange, Moderna Inc. priced a $1.34 billion follow-on offering to help fund worldwide manufacturing and distribution of its mRNA-1273 vaccine for COVID-19.Read More